Overview
Dilraj Grewal, MD is a tenured Associate Professor of Ophthalmology at the Duke Eye Center. He specializes in the medical and surgical management of patients with complex Vitreoretinal pathology and Uveitis. He joined the Duke Eye Center following completion of his Vitreoretinal Surgery fellowship at Duke and Uveitis fellowship training at Moorfields Eye Hospital in London. Dr. Grewal is excited about treating patients with new diagnostic and therapeutic modalities available as well as investigating several others in the pipeline to better help patients with these potentially blinding diseases.
He has been the recipient of numerous prestigious awards including the Ronald G. Michels Foundation Fellowship Award, the Heed Ophthalmic Foundation Fellowship Award, Senior Achievement Award from the American Academy of Ophthalmology and Rhett Buckler and Presidential Awards from American Society of Retina Specialists. He is an elected member of Retina Society, Clubs Jules Gonin and serves on the executive committee of the Macula Society.
Dr. Grewal has authored over 190 publications in peer-reviewed medical journals and over 250 presentations at national and international meetings. His research interests span assessment of retinal changes in neurodegenerative diseases, clinical research activities in advanced ocular imaging, surgical techniques and clinical trials for both Retina and Uveitis. Dr Grewal also serves as the Associate Director of the Duke Reading Center, a comprehensive image reading center that specializes in systematic analysis of ophthalmic images in multi-center clinical trials.
Current Appointments & Affiliations
Recent Publications
Possible Association Between Dopamine Antagonists and Increased Conversion to Exudative Age-Related Macular Degeneration.
Journal Article J Vitreoretin Dis · April 2, 2025 Purpose: To investigate whether modulating dopamine signaling affects conversion to exudative age-related macular degeneration (AMD). Methods: A retrospective cohort study was performed using the Duke Epic database. Eyes from patients with a diagnosis of n ... Full text Link to item CiteTrends in Choroidal Vascularity Index in Cognitively Normal Individuals.
Journal Article Retina · March 4, 2025 PURPOSE: To establish a normative database of choroidal vascularity index (CVI) in cognitively normal adults. METHODS: Cognitively healthy volunteers who had a Montreal Cognitive Assessment (MoCA) score of 23 or higher were included. Exclusion criteria inc ... Full text Link to item CiteReperfusion of macular vasculature in lupus-mediated occlusive vasculopathy.
Journal Article Can J Ophthalmol · February 2025 Full text Link to item CiteRecent Grants
A Phase IIb, Randomized, Assessor-Masked, Multicenter Clinical Trial To Assess The Safety And Efficacy Of Subretinal Implantation Of The CPCB-RPE1 Implant In Subjects With Advanced, Dry Age-Related Macular Degeneration (Geographic Atrophy)-PATCH AMD
ResearchPrincipal Investigator · Awarded by Clinical Trials Resource Group, LLC · 2024 - 2031A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2024 - 2029A Phase 1/2a study of subretinal administration of OpCT-001 photoreceptor precursor cells derived from iPSCs in patients with primary photoreceptor disease
ResearchPrincipal Investigator · Awarded by BlueRock Therapeutics LP · 2025 - 2029View All Grants